Olanzapine as Antiemetic Prophylaxis in Moderately Emetogenic Chemotherapy: A Phase 3 Randomized Clinical Trial.

MLA

Ostwal, Vikas, et al. “Olanzapine as Antiemetic Prophylaxis in Moderately Emetogenic Chemotherapy: A Phase 3 Randomized Clinical Trial.” JAMA Network Open, vol. 7, no. 8, Aug. 2024, p. e2426076. EBSCOhost, https://doi.org/10.1001/jamanetworkopen.2024.26076.

APA

Ostwal, V., Ramaswamy, A., Mandavkar, S., Bhargava, P., Naughane, D., Sunn, S. F., Srinivas, S., Kapoor, A., Mishra, B. K., Gupta, A., Sansar, B., Pal, V., Pandey, A., Bonda, A., Siripurapu, I., Muddu, V. K., Kannan, S., Chaugule, D., Patil, R., … Olver, I. (2024). Olanzapine as Antiemetic Prophylaxis in Moderately Emetogenic Chemotherapy: A Phase 3 Randomized Clinical Trial. JAMA Network Open, 7(8), e2426076. https://doi.org/10.1001/jamanetworkopen.2024.26076

Chicago

Ostwal, Vikas, Anant Ramaswamy, Sarika Mandavkar, Prabhat Bhargava, Deepali Naughane, Sharon Flavia Sunn, Sujay Srinivas, et al. 2024. “Olanzapine as Antiemetic Prophylaxis in Moderately Emetogenic Chemotherapy: A Phase 3 Randomized Clinical Trial.” JAMA Network Open 7 (8): e2426076. doi:10.1001/jamanetworkopen.2024.26076.